ABBV-744 clinical trial phase 2 data Things To Know Before You Buy
In Segment C, individuals will receive ABBV-744 and oral navitoclax. In Section D, participants will obtain ABBV-744 and ruxolitinib. Contributors will receive treatment till disease progression or perhaps the participants are not able to tolerate the study drugs.There might be increased treatment load for contributors In this particular trial when